Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide.
作者信息
Ryder Robert E J, Laubner Katharina, Benes Marek, Haluzik Martin, Munro Lynne, Frydenberg Harry, Teare Julian P, Ruban Aruchuna, Fishman Sigal, Santo Erwin, Stengel Rainer, De Jonge Charlotte, Greve Jan W, Cohen Ricardo V, Aboud Cristina M, Holtmann Gerald J, Rich Graeme, McMaster Jess J, Battelino Tadej, Kotnik Primoz, Byrne James P, Mason John C, Bessell Justin, Bascomb Jeanine, Kow Lillian, Collins Janes, Chisholm Jacob, Pferschy Peter N, Sourij Harald, Cull Melissa L, Wyres Melanie C, Drummond Russell, McGowan Barbara, Amiel Stephanie A, Yadagiri Mahi, Sen Gupta Piya, Aberle Jens, Seufert Jochen
机构信息
Diabetes and Endocrinology, Sandwell and West Birmingham Hospitals National Health Service Trust, Birmingham, U.K.
Division of Endocrinology and Diabetology, Department of Medicine II, University Hospital of Freiburg, Freiburg, Germany.
出版信息
Diabetes Care. 2023 Apr 1;46(4):e89-e91. doi: 10.2337/dc22-1952.
Abstract
摘要
相似文献
1
Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide.内镜下十二指肠-空肠旁路支架治疗2型糖尿病和肥胖症：全球1022例患者血糖及心血管疾病危险因素的改善情况
Diabetes Care. 2023 Apr 1;46(4):e89-e91. doi: 10.2337/dc22-1952.
2
Duodenal-jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3-year outcomes in the First National Health Service (NHS) EndoBarrier Service.十二指肠空肠旁路内衬治疗2型糖尿病和肥胖症：英国国家医疗服务体系（NHS）首个EndoBarrier服务项目的3年成果
Diabet Med. 2022 Jul;39(7):e14827. doi: 10.1111/dme.14827. Epub 2022 Mar 29.
3
Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation.24 个月十二指肠-空肠旁路管植入术后的体重减轻、血糖控制和安全性的临床随访。
Surg Endosc. 2020 Jan;34(1):209-215. doi: 10.1007/s00464-019-06752-8. Epub 2019 Mar 14.
4
The Effect of 6 and 12 months Duodenal-Jejunal Bypass Liner Treatment on Obesity and Type 2 Diabetes: a Crossover Cohort Study.十二指肠空肠旁路管 6 个月和 12 个月治疗对肥胖和 2 型糖尿病的影响：一项交叉队列研究。
Obes Surg. 2018 May;28(5):1255-1262. doi: 10.1007/s11695-017-2997-7.
5
Endoscopic Therapeutic Option for Weight Loss and Control of Type 2 Diabetes: the Duodenal-Jejunal Bypass Liner.用于减肥和控制2型糖尿病的内镜治疗选择：十二指肠-空肠旁路支架
Surg Technol Int. 2015 May;26:115-9.
6
Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study.十二指肠空肠旁路支架用于减轻体重及改善糖尿病：一项纳入198例患者的队列研究
Surg Endosc. 2017 Jul;31(7):2881-2891. doi: 10.1007/s00464-016-5299-6. Epub 2016 Nov 1.
7
Comparative efficacy and safety of the duodenal-jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control study.十二指肠-空肠旁路管在肥胖 2 型糖尿病患者中的疗效和安全性比较：病例对照研究。
Diabetes Obes Metab. 2018 Aug;20(8):1868-1877. doi: 10.1111/dom.13300. Epub 2018 Apr 23.
8
Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases.十二指肠空肠旁路术治疗体重指数为22 - 34 kg/m²的2型糖尿病患者：2例报告
Surg Obes Relat Dis. 2007 Mar-Apr;3(2):195-7. doi: 10.1016/j.soard.2007.01.009.
9
The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial.内镜下十二指肠-空肠旁路支架对肥胖症和2型糖尿病的影响：一项多中心随机对照试验
Ann Surg. 2014 Dec;260(6):984-92. doi: 10.1097/SLA.0000000000000794.
10
Efficacy of Sleeve Gastrectomy with Duodenal-Jejunal Bypass for the Treatment of Obese Severe Diabetes Patients in Japan: a Retrospective Multicenter Study.日本袖状胃切除术联合十二指肠-空肠旁路术治疗肥胖重症糖尿病患者的疗效：一项回顾性多中心研究
Obes Surg. 2018 Feb;28(2):497-505. doi: 10.1007/s11695-017-2874-4.
引用本文的文献
1
Obesity and Pancreatic Diseases: From Inflammation to Oncogenesis and the Impact of Weight Loss Interventions.肥胖与胰腺疾病：从炎症到肿瘤发生以及减肥干预措施的影响
Nutrients. 2025 Jul 14;17(14):2310. doi: 10.3390/nu17142310.
2
Emerging Trends in Endoscopic Bariatric Therapies: Personalization Through Genomics and Synergistic Pharmacotherapy.内镜减重治疗的新趋势：通过基因组学和协同药物治疗实现个性化
J Clin Med. 2025 Jul 2;14(13):4681. doi: 10.3390/jcm14134681.
3
The latest evidence and guidance in lifestyle and surgical interventions to achieve weight loss in people with overweight or obesity.关于超重或肥胖人群实现体重减轻的生活方式及手术干预的最新证据与指南。
Diabetes Obes Metab. 2025 Apr;27 Suppl 2(Suppl 2):20-34. doi: 10.1111/dom.16296. Epub 2025 Mar 3.
4
Amyloid-β and heart failure in Alzheimer's disease: the new vistas.阿尔茨海默病中的β-淀粉样蛋白与心力衰竭：新视野
Front Med (Lausanne). 2025 Feb 4;12:1494101. doi: 10.3389/fmed.2025.1494101. eCollection 2025.
5
The Role of Exerkines in Obesity-Induced Disruption of Mitochondrial Homeostasis in Thermogenic Fat.运动因子在肥胖诱导的产热脂肪线粒体稳态破坏中的作用
Metabolites. 2024 May 17;14(5):287. doi: 10.3390/metabo14050287.
6
Role of endoscopic duodenojejunal bypass liner in obesity management and glycemic control.内镜十二指肠空肠旁路支架在肥胖管理和血糖控制中的作用。
Clin Endosc. 2024 May;57(3):309-316. doi: 10.5946/ce.2023.217. Epub 2024 Feb 15.
本文引用的文献
1
Duodenal-jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3-year outcomes in the First National Health Service (NHS) EndoBarrier Service.十二指肠空肠旁路内衬治疗2型糖尿病和肥胖症：英国国家医疗服务体系（NHS）首个EndoBarrier服务项目的3年成果
Diabet Med. 2022 Jul;39(7):e14827. doi: 10.1111/dme.14827. Epub 2022 Mar 29.
2
Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes.十二指肠-空肠旁路管对肥胖 2 型糖尿病患者血糖控制的影响：一项荟萃分析及对体重减轻和激素变化的二次分析。
Diabetes Care. 2018 May;41(5):1106-1115. doi: 10.2337/dc17-1985.
Zotero 插件